MYOF and pancreatic ductal adenocarcinoma: High expression of Myoferlin is associated with poor patient outcome in oropharyngeal squamous cell carcinoma [25], and poor prognosis in pancreatic ductal adenocarcinoma [26], clear cell renal cell carcinoma [27], and colon cancer [28].